Engineering a TCR-like Anti-PR1/HLA-A2 Antibody Scfv in a Novel Chimeric Antigen Receptor (CAR) to Redirect T Cells to Eliminate Myeloid Leukemia

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION(2016)

引用 0|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要